TITLE

Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy

AUTHOR(S)
Chhablani, Jay Kumar
PUB. DATE
May 2011
SOURCE
Indian Journal of Ophthalmology;May2011, Vol. 59 Issue 3, p256
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to an article about anti-vascular endothelial growth factor drugs.
ACCESSION #
60948890

 

Related Articles

  • Persistent Elevation of VEGF and Prostacyclin Following Poor Cardiopulmonary Adaptation to High Altitude. White, Michel; Touyz, Rhian; Tessier, Yves; Vy Van Le; Ross, Heather; Sirois, Martin G. // Wilderness & Environmental Medicine;Spring2009, Vol. 20 Issue 1, p97 

    A letter to the editor is presented about the persistent elevation of vascular endothelial growth factor (VEGF) and prostacyclin following poor cardiopulmonary adaptation to high altitude.

  • Bevacizumab in Renal-Cell Cancer. Sonpavde, Guru // New England Journal of Medicine;10/23/2003, Vol. 349 Issue 17, p1674 

    A letter to the editor is presented in response to the article "A Randomized Trial of Bevacizumab, An Antivascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer," by J. C. Yang, L. Haworth, R. M. Sherry et al. in the July 31, 2003 issue.

  • Comment on 'Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab'. Vallance, J H // Eye;Jan2012, Vol. 26 Issue 1, p167 

    A letter to the editor and a response to the article "Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab," by C. H. Meyer and F. C. Holz in the 2011 issue are presented.

  • Expression of HIF-1α in human tumours. Jubb, A.; Hillan, K. // Journal of Clinical Pathology;Dec2005, Vol. 58 Issue 12, p1344 

    A letter to the editor is presented discussing vascular endothelial growth factor.

  • Angiogenic balance and diagnosis of pre-eclampsia: selecting the right VEGF receptor. Jha, V; Aggarwal, P K; Chandel, N; Jain, V // Journal of Human Hypertension;Mar2012, Vol. 26 Issue 3, p205 

    A letter to the editor is presented in response to an article by G. Rath and R. Tripathi on serum vascular endothelial growth factor (VEGF) in hypertensive disorders of pregnancy, which was published in a previous issue.

  • Serum VEGF, blood transfusion, and wound orientation. Nash, G. F.. // Surgical Endoscopy;Oct2008, Vol. 22 Issue 10, p2328 

    A letter to the editor is presented about serum vascular endothelial growth factor (VEGF), blood transfusion and wound orientation.

  • Retinking VEGF Treatment Failures. Nelson, Mark // Review of Ophthalmology;May2008, Vol. 15 Issue 5, p13 

    A letter to the editor is presented in response to the article "When Anti-VEGF Treatment Fails, Retinal Insider," by Ron Gallemore in the March 2008 issue.

  • In reply. Gallemore, Ron P. // Review of Ophthalmology;May2008, Vol. 15 Issue 5, p13 

    A response by Ron P. Gallemore to a letter to the editor about his article "When Anti-VEGF Treatment Fails, Retinal Insider" in the March 2008 issue is presented.

  • Plasma VEGF as a marker for the diagnosis and treatment of vasculitic neuropathy. Sakai, K.; Komal, K.; Yanase, D.; Yamada, M.; Komai, K // Journal of Neurology, Neurosurgery & Psychiatry;Feb2005, Vol. 76 Issue 2, p296 

    Presents a letter to the editor suggesting plasma vascular endothelial growth factor as a marker for the diagnosis and treatment of vasculitic neuropathy.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics